UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 10-Q

 


 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the quarterly period ended September 30, 2022Quarterly Period Ended March 31, 2023

or

 ☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the transition period fromFrom                            to                        

 

Commission File Number 000-50009

 

PACIFIC HEALTH CARE ORGANIZATION, INC.

(Exact name of registrant as specified in its charter)

 

 

Utah

87-0285238

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

19800 MacArthur Boulevard, Suites 306 & 307

 

Irvine, California

92612

(Address of principal executive offices)

(Zip Code)

 

(949) 721-8272

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading symbol

 

Name of each exchange on which registered

None

 

N/A

 

N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for any shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.) Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “largelarge accelerated filer,“acceleratedaccelerated filer,“smallersmaller reporting company”company and “emergingemerging growth company”company in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐  

Accelerated filer ☐

Non-accelerated filer ☒

Smaller reporting company ☒

 

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes ☐ No ☒

 

As of November 11, 2022,May 18, 2023, the registrant had 12,800,000 shares of common stock, par value $0.001, issued and outstanding.

 

 

 

 

PACIFIC HEALTH CARE ORGANIZATION, INC.

FORM 10-Q

TABLE OF CONTENTS

 

 

Page

PART I  FINANCIAL INFORMATION

 

 

 

Item 1. Condensed Consolidated Financial Statements

3

 

 

 

(Unaudited) Balance Sheets as of September 30, 2022March 31, 2023 and December 31, 20212022

3

 

 

 

 

(Unaudited) Statements of Operations for the Three and Nine Months Ended September 30,March 31, 2023 and 2022 and 2021

4

 

 

 

 

(Unaudited) Statements of Stockholders’ Equity for the Three and Nine Months Ended September 30,March 31, 2023 and 2022 and 2021

5

 

 

 

 

(Unaudited) Statements of Cash Flows for the NineThree Months Ended September 30,March 31, 2023 and 2022 and 2021

6

 

 

 

 

Notes to Condensed Consolidated Financial Statements (Unaudited)

7

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

1011

 

 

Item 3. Quantitative and Qualitative Disclosure about Market Risk

2423

 

Item 4. Controls and Procedures

2423

 

 

PART II  OTHER INFORMATION

 

 

 

Item 1A. Risk Factors

2524

 

 

Item 6. Exhibits

2524

 

 

Signatures

2625

 

 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Information

Pacific Health Care Organization, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

 

 

September 30,

  

December 31,

  

March 31,

  

December 31,

 
 

2022

  

2021

  

2023

  

2022

 

ASSETS

                

Current Assets

                

Cash

 $10,640,063  $10,085,372  $1,994,841  $2,036,432 

Accounts receivable, net of allowance of $7,696 and $23,083

  864,070   927,990 

Deferred rent assets

  -   10,055 

Investments

  8,848,251   8,748,435 

Accounts receivable, net of allowance of $8,037 and $7,807

  997,731   934,990 

Receivable – other

  3,000   3,000   3,000   3,000 
Income tax receivable -  19,779 

Prepaid expenses

  157,336   96,977   170,198   175,355 

Total current assets

  11,664,469   11,143,173   12,014,021   11,898,212 
                

Property and Equipment, net

                

Computer equipment

  277,716   526,249   256,709   256,500 

Furniture and fixtures

  20,928   226,323   20,328   20,328 

Office equipment

  -   9,556 

Total property and equipment

  298,644   762,128   277,037   276,828 

Less: accumulated depreciation and amortization

  (211,642

)

  (669,592

)

  (188,802

)

  (179,423

)

Net property and equipment

  87,002   92,536   88,235   97,405 

Operating lease right-of-use assets, net

  -   70,368   41,198   50,137 

Other assets

  6,602   26,788   7,110   6,602 

Total Assets

 $11,758,073  $11,332,865  $12,150,564  $12,052,356 
                

LIABILITIES AND STOCKHOLDERS EQUITY

        

LIABILITIES AND STOCKHOLDERS’ EQUITY

        
                

Current Liabilities

                

Accounts payable

 $89,337  $44,899  $227,322  $263,022 

Accrued expenses

  247,274   315,495   287,563   332,551 

Income tax payable

  54,295   3,132 

Dividend payable

  37,000   37,000   37,000   37,000 

Income tax payable

  7,316   - 

Operating lease liabilities, current portion

  -   70,368   30,681   39,620 

Unearned revenue

  40,523   33,544   39,107   33,544 

Total current liabilities

  421,450   501,306   675,968   708,869 
                

Long Term Liabilities

                

Operating lease liabilities, long-term portion

  -   - 

Operating lease liabilities, long term portion

  10,517   10,517 

Deferred tax liabilities

  7,154   7,154   15,679   15,679 

Total Liabilities

  428,604   508,460  $702,164  $735,065 
                

Commitments and Contingencies

   -    -   -   - 
                

Stockholders Equity

        

Preferred stock - $0.001 par value, 5,000,000 shares authorized of which 40,000 shares designated as Series A preferred and 16,000 shares issued and outstanding

 $16  $16 

Common stock - $0.001 par value, 800,000,000 shares authorized, 12,800,000 shares issued and outstanding

  12,800   12,800 

Stockholders’ Equity

        

Convertible preferred stock, $0.001 par value, 5,000,000 shares authorized of which 40,000 shares designated as Series A preferred and 16,000 shares issued and outstanding

  16   16 

Common stock, $0.001 par value, 800,000,000 shares authorized, 12,800,000 shares issued and outstanding

  12,800   12,800 

Additional paid-in capital

  416,057   416,057   416,057   416,057 

Retained earnings

  10,900,596   10,395,532   11,019,527   10,888,418 

Total Stockholders’ Equity

  11,329,469   10,824,405 
        

Total stockholders’ equity

  11,448,400   11,317,291 

Total Liabilities and Stockholders’ Equity

 $11,758,073  $11,332,865  $12,150,564  $12,052,356 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3

 

Pacific Health Care Organization, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

 

 

For three months ended

September 30,

  

For nine months ended

September 30,

  

For three months ended

March 31,

 
 

2022

  

2021

  

2022

  

2021

  

2023

  

2022

 

Revenues

                

Revenues:

        

HCO

 $354,913  $289,117  $985,192  $936,382  $278,322  $360,968 

MPN

  128,297   137,834   422,227   396,497   129,094   148,611 

Medical bill review

  89,785   120,337 

Utilization review

  443,049   258,251   1,220,941   796,927   445,712   354,956 

Medical bill review

  99,418   117,685   333,310   292,445 

Medical case management

  384,657   439,073   1,218,077   1,381,929   332,373   418,762 

Other

  43,663   68,658   102,084   174,251   37,357   23,749 

Total revenues

  1,453,997   1,310,618   4,281,831   3,978,431   1,312,643   1,427,383 
                        

Expenses

                

Expenses:

        

Depreciation

  9,661   12,657   23,153   35,964   9,379   4,195 

Bad debt provision

  (5,520)  -   (737

)

  494   230   4,783 

Consulting fees

  56,148   58,275   166,309   173,796   56,254   53,955 

Salaries and wages

  699,026   679,530   2,018,638   2,073,133   662,224   633,372 

Professional fees

  76,065   76,014   222,703   221,970   73,102   66,864 

Insurance

  79,974   86,527   238,851   242,334   83,481   83,666 

Outsource service fees

  156,677   109,926   433,275   304,085   177,759   143,778 

Data maintenance

  2,898   11,917   59,400   75,293   34,002   10,189 

General and administrative

  112,135   168,939   418,079   492,264   133,756   164,472 

Total expenses

  1,187,064   1,203,785   3,579,671   3,619,333   1,230,187   1,165,274 
                        

Income from operations

  266,933   106,833   702,160   359,098   82,456   262,109 
                        

Other income (expense)

                

Paycheck protection program loan forgiveness income

  -   -   -   464,386 

Paycheck protection program loan interest expense

  -   -   -   (3,686

)

Other income (expense):

        

Interest income

  99,816   - 

Total other income (expense)

  -   -   -   460,700   99,816   - 
                        

Income before taxes

  266,933   106,833   702,160   819,798   182,272   262,109 

Income tax provision

  74,928   29,987   197,096   140,956   (51,163)  (73,574

)

                        

Net income

 $192,005  $76,846  $505,064  $678,842  $131,109  $188,535 
                        

Basic earnings per share:

                        

Earnings per share amount

 $0.02  $0.01  $0.04  $0.05  $0.01  $0.01 

Basic common shares outstanding

  12,800,000   12,800,000   12,800,000   12,800,000   12,800,000   12,800,000 
                        

Fully diluted earnings per share:

                        

Earnings per share amount

 $0.01  $0.01  $0.04  $0.05  $0.01  $0.01 

Fully diluted common shares outstanding

  12,816,000   12,816,000   12,816,000   12,816,000   12,816,000   12,816,000 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

Pacific Health Care Organization, Inc.

Condensed Consolidated Statements of Stockholders' Equity

(Unaudited)

 

  

Preferred Stock

  

Common Stock

  

Additional

Paid-in

  

Retained

  

Total

Stockholders’

 
  

Shares

  

Amount

  

Shares

  

Amount

  

Capital

  

Earnings

  

Equity

 

Balances at December 31, 2020

  16,000  $16   12,800,000  $12,800  $416,057  $9,400,512  $9,829,385 

Net Income

  -   -   -   -   -   507,285   507,285 

Balances at March 31, 2021

  16,000  $16   12,800,000  $12,800  $416,057  $9,907,797  $10,336,670 

Net Income

  -   -   -   -   -   94,711   94,711 

Balances at June 30, 2021

  16,000  $16   12,800,000  $12,800  $416,057  $10,002,508  $10,431,381 

Net Income

  -   -   -   -   -   76,846   76,846 

Balances at September 30, 2021

  16,000  $16   12,800,000  $12,800  $416,057  $10,079,354  $10,508,227 
                             

Balances at December 31, 2021

  16,000  $16   12,800,000  $12,800  $416,057  $10,395,532  $10,824,405 

Net Income

  -   -   -   -   -   188,535   188,535 

Balances at March 31, 2022

  16,000  $16   12,800,000  $12,800  $416,057  $10,584,067  $11,012,940 

Net Income

  -   -   -   -   -   124,524   124,524 

Balances at June 30, 2022

  16,000  $16   12,800,000  $12,800  $416,057  $10,708,591  $11,137,464 

Net Income

  -   -   -   -   -   192,005   192,005 

Balances at September 30, 2022

  16,000  $16   12,800,000  $12,800  $416,057  $10,900,596  $11,329,469 
  

Convertible

Preferred Stock

  

Common Stock

  

Paid in

  

Retained  

  

Total

Stockholders’

 
  

Shares

  

Amount

  

Shares

  

Amount

  

Capital

  

Earnings

  

Equity

 

Balance December 31, 2021

  16,000  $16   12,800,000  $12,800  $416,057  $10,395,532  $10,824,405 
                             

Net income

  -   -   -   -   -   188,535   188,535 
                             

Balance March 31, 2022

  16,000  $16   12,800,000  $12,800  $416,057  $10,584,067  $11,012,940 
                             

Balance December 31, 2022

  16,000  $16   12,800,000  $12,800  $416,057  $10,888,418  $11,317,291 
                             

Net income

  -   -   -   -   -   131,109   131,109 
                             

Balance March 31, 2023

  16,000  $16   12,800,000  $12,800  $416,057  $11,019,527  $11,448,400 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5

 

Pacific Health Care Organization, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

 

Nine Months Ended

September 30,

  

Three Months Ended

March 31,

 
 

2022

  

2021

  

2023

  

2022

 

Cash flows from operating activities:

                

Net income

 $505,064  $678,842  $131,109  $188,535 

Adjustments to reconcile net income to net cash provided by operating activities:

        

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

        

Depreciation

  23,153   35,964   9,379   4,195 

Bad debt provision

  (737

)

  494   230   4,783 

Paycheck protection program loan forgiveness

  -   (460,700

)

Noncash interest on investments

  (99,816

)

  - 
                

Changes in operating assets and liabilities:

                

Decrease in accounts receivable

  64,657   276,484 

Decrease in receivable – other

  -   1,000 

(Increase) decrease in prepaid expenses

  (60,359

)

  8,287 

Increase (decrease) in accounts payable

  44,438   (21,129

)

Decrease in deferred rent expense

  -   (2,725

)

Decrease in taxes receivable 19,779  - 

Decrease in accrued expenses

  (68,221

)

  (19,643

)

Increase (decrease) in income tax payable

  7,316   (52,045

)

Decrease (increase) in deferred rent assets

  10,055   (607

)

Decrease in other assets

  20,186   - 

(Increase) decrease in accounts receivable

  (62,971

)

  120,930 

Increase in deferred rent assets

  -   (14,298)

Decrease in prepaid expenses

  5,157   14,997 

Increase in taxes receivable

  -   (35,620

)

Increase in other assets

  (508

)

  (6,602

)

(Decrease) increase in accounts payable

  (35,700

)

  16,938 

(Decrease) increase in accrued expenses

  (44,988

)

  51,076 

Increase in unearned revenue

  6,979   5,771   5,563   5,243 

Net cash provided by operating activities

  572,310   449,993 

Increase in income tax payable

  51,163   109,193 

Net cash provided by (used in) operating activities

  (41,382

)

  459,370 
                

Cash flows from investing activities:

                

Purchase of furniture and office equipment

  (17,619)  (12,199

)

  (209

)

  (6,133

)

Net cash used in investing activities

  (17,619)  (12,199

)

  (209

)

  (6,133

)

                

Cash flows from financing activities:

                

Proceeds from paycheck protection program loans

  -   218,900 

Net cash provided by financing activities

  -   218,900   -   - 

Increase in cash

  554,691   656,694 

Net increase (decrease) in cash

  (41,591

)

  453,237 
                

Cash at beginning of period

  10,085,372   9,498,457   2,036,432   10,085,372 

Cash at end of period

 $10,640,063  $10,155,151  $1,994,841  $10,538,609 
                

Supplemental cash flow information

        

Supplemental cash flow information:

        

Cash paid for:

                

Interest

 $-  $(3,686

)

 $-  $- 

Income taxes

 $170,000  $69,000  $-  $63,000 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

6

 

Pacific Health Care Organization, Inc.

Notes to the Condensed Consolidated Financial Statements

For the NineThree Months Ended September 30, 2022March 31, 2023

(Unaudited)

 

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION

 

The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”) and in accordance with accounting principles generally accepted in the United States (“GAAP”). Certain information and footnote disclosures normally included in consolidated financial statements have been condensed or omitted in accordance with GAAP rules and regulations. The information furnished in these interimunaudited condensed consolidated financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect both the recorded values of assets and liabilities at the date of the condensed consolidated financial statements and the revenues recognized and expenses incurred during the reporting period. These estimates and assumptions affect the Company’s recognition of deferred expenses, bad debts, income taxes, the carrying value of its long-lived assets and its provision for certain contingencies. The reasonableness of these estimates and assumptions is evaluated continually based on a combination of historical and other information that comes to the Company’s attention that may vary its outlook for the future. While management believes the disclosures and information presented are adequate to make the information not misleading, the Company recommends these interimunaudited condensed consolidated financial statements be read in conjunction with its audited financial statements and notes thereto included in its annual report on Form 10-K for the year ended December 31, 2021.2022. Operating results for the ninethree months ended September 30, 2022,March 31, 2023, are not necessarily indicative of the results to be expected for the year ending December 31, 2022.2023.

 

Principles of Consolidation — The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany transactions and balances have been eliminated in consolidation.

 

Basis of Accounting — The Company uses the accrual method of accounting in accordance with accounting principles generally accepted in the United States for the periods ended September 30, 2022March 31, 2023 and 2021.2022.

 

Revenue Recognition — The Company recognizes revenue in accordance with ASC 606,ASU 2014-09, “Revenue from Contracts with Customers.Customers (Topic 606).” The core principle underlying ASCTopic 606 is that the Company will recognize revenue to represent the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer.

 

ASC 606 requires the use of a five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation. Revenues are generated as services are provided to the customer based on the sales price agreed and collected. The Company recognizes revenue as the time is worked or as units of production are completed, which is when the revenue is earned and realized. Labor costs are recognized as the costs are incurred.

 

The Company derives its revenue from the sale of services offered through its HCOs, MPNs, utilization review, medical bill review, medical case management services, lien defense,representation, carve-outs, Medicare set-aside. These services are billed individually as separate components to our customers. These fees include monthly and/or annual HCO and/or MPN administration fees, claim and network access fees, medical bill review fees, legal support fees, Medicare set-aside fees, lien service fees, workers’ compensation carve-outs, utilization review fees, medical case management flat rate fees or hourly fees depending on the agreement with the customer.

 

7

 

Pacific Health Care Organization, Inc.

Notes to the Condensed Consolidated Financial Statements

For the NineThree Months Ended September 30, 2022March 31, 2023

(Unaudited)

 

The Company enters arrangements for bundled managed care, standalone services, or add-on ancillary services which include various units of accounting such as network solutions and patient management, including managed care. Such elements are considered separate units of accounting due to each element having value to the customer on a stand-alone basis and are billed separately. The selling price for each unit of accounting is determined using the contract price. When the Company’s customers purchase several products the pricing of the products sold is generally the same as if the products were sold on an individual basis. Revenue is recognized as the work is performed in accordance with the Company’s customer contracts. Based upon the nature of the Company’s products, bundled managed care elements are generally delivered in the same accounting period. The Company recognizes revenue for patient management services ratably over the life of the customer contract. Based upon prior experience in managed care, the Company estimates the deferral amount from when the customer’s claim is received to when the customer contract expires. Advance payments from subscribers and billings made in advance are recorded on the balance sheet as deferred revenue.

Accounts Receivables and Bad Debt Allowance – In the normal course of business the Company extends credit to its customers on a short-term basis. Although the credit risk associated with these customers is minimal, the Company routinely reviews its accounts receivable balances and makes provisions for doubtful accounts. The Company ages its receivables by dates of invoices. Management reviews bad debt reserves quarterly and reserves specific accounts as warranted or sets up a general reserve based on amounts over 90 days past due. When an account is deemed uncollectible, the Company charges off the receivable against the bad debt reserve. A considerable amount of judgment is required in assessing the realization of these receivables including the current creditworthiness of each customer and related aging of the past-due balances, including any billing disputes. To assess the collectability of these receivables, the Company performs ongoing credit evaluations of its customers’ financial condition. Through these evaluations, the Company may become aware of situations where a customer may not be able to meet its financial obligations due to deterioration of its financial viability, credit rating or bankruptcy. The allowance for doubtful accounts is based on the best information available to the Company and is reevaluated and adjusted as additional information is received. The Company evaluates the allowance based on historical write-off experience, the size of the individual customer balances, past-due amounts, and the overall national economy. At September 30, 2022March 31, 2023 and December 31, 2021,2022, bad debt reserves of $7,696$8,037 and $23,083,$7,807, respectively, were maintained in a general reserve for certain balances over 90 days past due and for accounts that are potentially uncollectible.

 

The percentages of the amounts due from major customers to total accounts receivable as of September 30, 2022March 31, 2023 and December 31, 2021,2022, are as follows:

 

 

9/30/2022

  

12/31/2021

  

3/31/2023

  

12/31/2022

 

Customer A

  25

%

  24

%

  46

%

  18

%

Customer B

  11

%

  11

%

  -

%

  24

%

 

Significant Customers - The Company provides services to insurers, third party administrators, self-administered employers, municipalities, and other industries. The Company is able to provide its full range of services to virtually any size employer in the state of California. Outside the state of California, the Company is able to provide utilization review, medical bill review and medical case management services.

 

During the periodperiods ended September 30,March 31, 2023 and 2022, and 2021, the Company had two customers, respectively, that individually accounted for more than 10% of its total sales. The following table sets forth details regarding the percentages of total sales attributable to the Company’s significant customers in the past two years:

 

 

9/30/2022

  

9/30/2021

  

3/31/2023

  

3/31/2022

 

Customer A

  28

%

  25

%

  24

%

  22

%

Customer B

  10

%

  11

%

  10

%

  10

%

 

Leases - The Company follows the guidance of ASC 842, Leases, which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The Company elected to exclude from its balance sheets recognition of leases having a term of 12 months or less (“short-term leases”).less. Lease expense is recognized on a straight-line basis over the lease term. See Note 2 for further information regarding the Company’s leases.

 

8

Pacific Health Care Organization, Inc.

Notes to the Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2023

(Unaudited)

NOTE 2 - OPERATING LEASES

 

In July 2015,On April 1, 2022, the Company enteredmoved office locations from 1201 Dove Street, Suite 300 in Newport Beach, California to 19800 MacArthur Boulevard, Suite 300, in Irvine, California. This lease expires as of March 31, 2023, but was renewed on December 10, 2022, for an additional 12-month lease, with a 79-monthnew expiration of March 31, 2024. The Company elected to exclude from its balance sheets recognition of leases having a term of 12 months or less. Lease expense is recognized on a straight-line basis over the lease term. If a Company lease does not provide an implicit rate, the Company develops an estimated incremental borrowing rate at the commencement date based on the estimated rate at which it would borrow, in the current economic environment, in an amount equal to the lease payments over a similar term on a collateralized basis, which is used to determine the present value of lease payments. The Company had no finance leases at December 31, 2022 and 2021.

Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for approximately 9,439 square feetthe lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Generally, the implicit rate of office space, whichinterest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease commenced in September 2015payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The ROU assets include any lease payments made and ended in April 2022. That office space served as the Company’s principal executive offices, as well as the principal offices of its operating subsidiaries.exclude lease incentives.

 

The Company entered a new 12-month officecomponents of lease that commenced on April 1, 2022 with a monthly rent of $3,301. expense and supplemental cash flow information related to leases for the period are as follows:

  

Three Months Ended

March 31, 2023

 

Lease Cost

    

Operating lease cost (included in general and administrative in the Company’s consolidated statement of operations)

 $42,660 
     

Other Information

    

Cash paid for amounts included in the measurement of lease liabilities for the three months ended March 31, 2023

 $9,903 

Weighted average remaining lease term – operating leases (in years)

 

1 year

 

Average discount rate – operating leases

  5.75

%

The lease provides 320 square feet of office space that includes shared spacesupplemental balance sheet information related to leases for other business needs and expires March 31, 2023. This office space now servesthe period is as the principal executive offices of the Company, as well as the principal officesfollows:

  

At March 31, 2023

  

At December 31, 2022

 

Operating leases

        

Remaining right-of-use assets

 $41,198  $50,137 

Short-term operating lease liabilities

 $30,681  $39,620 

Long-term operating lease liabilities

  10,517   10,517 

Total operating lease liabilities

 $41,198  $50,137 

Maturities of the Company’s operating subsidiaries. The Company has reduced its office spaceundiscounted lease liabilities are as the majority of its workforce will continue working remotely. The new office space will be for the executive team and shared office space for key employees to use as needed.follows:

Year Ending

 

Operating Leases

 

2023

 $30,681 

2024

  10,517 

Total lease payments

  41,198 

Less: Imputed interest/present value discount

  1,462 

Present value of lease liabilities

 $39,736 

 

Lease expenses were $9,903$9,963 and $80,246$75,584 during the three months ended September 30,March 31, 2023 and 2022, and 2021, respectively, and $19,806 and $204,651 during the nine months ended September 30, 2022 and 2021, respectively.

 

8
9

 

Pacific Health Care Organization, Inc.

Notes to the Condensed Consolidated Financial Statements

For the NineThree Months Ended September 30, 2022March 31, 2023

(Unaudited)

 

NOTE 3 - PAYCHECK PROTECTION PROGRAM LOANS

In February 2021 the principal and interest on the Paycheck Protection Program (“PPP”) loans in the aggregate amount of $460,700 (the “first draw PPP loans”) issued to PHCO, MMC and MMM in April and May 2020 were forgiven in full.

Economic Aid Act

In December 2021 the principal and interest on section 311 of the Economic Aid Act Paycheck Protection Program Second Draw Loans in the amount of $218,900 (the “second draw PPP loan”) issued to MMM in April 2021 were forgiven in full.

NOTE 43 - SUBSEQUENT EVENTS

 

In accordance with ASC 855-10 Company management reviewed all material events through the date of issuance and except as disclosed below,has determined that there are no material subsequent events to report.

 

910

 

Item 2. Managements Discussion and Analysis of Financial Statements and Results of Operations

 

Throughout this quarterly report, unless the context indicates otherwise, the terms, “we,” “us,” “our” or the “Company” refer to Pacific Health Care Organization, Inc., (“PHCO”) and our wholly-owned subsidiaries Medex Healthcare, Inc. (“Medex”), Medex Managed Care, Inc. (“MMC”) and Medex Medical Management, Inc. (“MMM”), and, where applicable, our former subsidiaries Industrial Resolutions Coalition (“IRC”), Medex Legal Support, Inc. (“MLS”) and Pacific Medical Holding Company, Inc. (“PMHC”).

 

All statements other than statements of historical fact included herein and in the documents incorporated by reference in this quarterly report on Form 10-Q (this “quarterly report”), if any, including without limitation, statements regarding our future financial position or results of operations, business strategy, potential acquisitions, budgets, projected costs, and plans and objectives of management for future operations, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “foresee,” “future,” “intend,” “likely,” “may,” “might,” “objective,” “plan,” “potential,” “predict,” “project,” “should,” “strategy,” “will,” “would,” and other similar expressions and their negatives.

 

Forward-looking statements are not guarantees of future performance and involve known and unknown risks and uncertainties, many of which may be beyond our control. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof, and actual results could differ materially as a result of various factors. The following include some but not all of the factors that could cause actual results or events to differ materially from anticipated results or events:

 

economic conditions generally and in the industry in which we and our customers participate, including the effects resulting from economic recessions, international conflicts and rising domestic inflation;

cost reduction efforts by our existing and prospective customers;

the loss, ineffective management, malfunction or increased costs of third-party-provided technologies and services on which our operations rely;

competition within our industry, including competition from much larger competitors;

business combinations among our customers or competitors;

legislative and regulatory requirements or changes which could render our services less competitive or obsolete;

our failure to successfully develop new services and/or products either organically or through acquisition, or to anticipate current or prospective customers’ needs;

our ability to retain existing customers and to attract new customers;

price increases;

cybersecurity breaches and software system failures, or the imposition of laws imposing costly cybersecurity and data protection compliance;

the impacts on our business of COVID-19, including the reduction of our customers’ workforces as a result of a variety of COVID-19-related causes, as well as government mandates and impacts on the workers’ compensation industry, the businesses of our customers and on the economy generally;

reductions in worker’s compensation claims or the demand for our services, from whatever source; and

delays, reductions or cancellations of contracts we have previously entered.

         ●         the impacts on our business of COVID-19, including the reduction of our customers’ workforces as a result of a variety of COVID-19-related causes, as well as government mandates and impacts on the workers’ compensation industry, the businesses of our customers and on the economy generally;

         ●         economic and labor market conditions generally and in the industry in which we and our customers participate, including the effects resulting from economic recessions, financial sector turmoil, international conflicts, and rising domestic inflation and related economic policy responses;

         ●         the loss, ineffective management, malfunction (including those resulting from cybersecurity breaches), or increased costs of third-party-provided technologies and services on which our operations rely;

         ●         cybersecurity incidences and breaches, and other software system failures, and the imposition of laws imposing costly cybersecurity and data protection compliance;

         ●         reductions in worker’s compensation claims or the demand for our services, from whatever source;

         ●         cost reduction efforts by our existing and prospective customers;

         ●         price increases to the technologies and other services we rely on for our business;

         ●         business combinations among our customers or competitors;

         ●         the loss of or inability to obtain adequate insurance coverage;

         ●         competition within our industry, including competition from much larger competitors;

         ●         our ability to retain existing customers and to attract new customers;

         ●         delays, reductions, or cancellations of contracts we have previously entered;

         ●         legislative and regulatory requirements or changes which could render our services less competitive or obsolete; and

         ●         our failure to successfully develop new services and/or products either organically or through acquisition, or to anticipate current or prospective customers’ needs.

11

 

For more detailed information about particular risk factors related to us and our business, see Item 1A Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2021,2022, filed with the Securities and Exchange Commission (the “Commission”) on April 14, 2022March 31, 2023 (the “annual report”“Annual Report”).

 

We operate in a competitive and rapidly changing environment. New risk factors emerge from time to time, and it is not possible for our management to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

 

You should not place undue reliance on forward-looking statements. The forward-lookingForward-looking statements are based on the beliefs of management as well as assumptions made by and information currently available to management and apply only as of the date of this report or the respective dates of the documents from which it incorporates by reference. Neither we nor any other person assumes any responsibility for the accuracy or completeness of forward-looking statements. Further, except to the extent required by law, we undertake no obligations to update or revise any forward-looking statements, whether as a result of new information, future events, or a change in events, conditions, circumstances, or assumptions underlying such statements, or otherwise. We may also make additional forward-looking statements from time to time. All suchAny subsequent forward-looking statements, whether written or oral, made by us or on our behalf, are also expressly qualified by these cautionary statements.

10

 

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes contained elsewhere in this quarterly report and in our other filings with the Commission.

 

Overview

 

We incorporated under the laws of the state of Utah in April 1970, under the name Clear Air, Inc. We changed our name to Pacific Health Care Organization, Inc., in January 2001. In February 2001, we acquired Medex, a California corporation organized in March 1994, in a share for share exchange. Medex is in the business of managing and administering both Health Care Organizations (“HCOs”) and Medical Provider Networks (“MPNs”) in the state of California. In August 2001 we formed IRC, a California corporation, as a wholly owned subsidiary of PHCO. Prior to closing IRC, IRC oversaw and managed our Workers’ Compensation carve-outs services. In June 2010, we acquired MLS, a Nevada corporation incorporated in September 2009. Prior to closing MLS, MLS offered lien representation services and Medicare set-aside services (“MSA”). In February 2012, we incorporated MMM, a Nevada corporation, as a wholly owned subsidiary of the Company. MMM is responsible for overseeing and managing medical case management services. In March 2011, we incorporated MMC, a Nevada corporation, as a wholly owned subsidiary of the Company. MMC oversees and manages the Company’s utilization review and bill review services. In October 2018, we incorporated PMHC, a Nevada corporation, as a wholly owned subsidiary of the Company to act as a holding company for future potential acquisitions.

 

In October 2021, to simplify business procedures, bookkeeping and administrative structure; and eliminate duplicative functions and reduce costs; we terminated the existence of IRC, MLS and PMHC and wound up those subsidiaries. The business, assets, liabilities, and services of those entities were transferred to PHCO or its other subsidiaries. Medex now offers our Workers’ Compensation carve-out services previously provided by IRC and Medicare-set asides previously managed by MLS. MMC oversees the lien representation services previously offered by MLS.

 

Business of the Company

 

We offer an integrated and layered array of complimentarycomplementary business solutions that enable our customers to better manage their employee Workers’ Compensation-relatedworkers’ compensation-related healthcare administration costs. We are constantly looking for ways to expand the suite of services we can provide our customers, either through strategic acquisitions or organic development.

 

Our business objective is to deliver value to our customers by reducing their Workers’ Compensation-relatedworkers’ compensation-related medical claims expense in a manner that will assure that injured employees receive high quality healthcare that allows them to recover from injury and return to gainful employment without undue delay. According to studies conducted by auditing bodies on behalf of the California Division of Workers’ Compensation, (“DWC”) the two most significant cost drivers for Workers’ Compensationworkers’ compensation are claims frequency and medicallonger than average treatment costs.duration. Our services focus on containingensuring timely medical treatment to reduce the claim duration and medical treatment costs.

 

12

We offer our

Our services include providing customers access to our HCOs and our MPNs. We also provide medical case management, field medical case management, network access, utilization review, medical bill review, Workers’ Compensationutilization review, workers’ compensation carve-outs and Medicare set-aside services. Additionally,Complementary to these services, we offeralso provide lien representation and expert witness testimony, ancillary to our services.testimony. We provideoffer our services as a bundled solution, as standalone services, or as add-on services.

 

Our core services focus on reducing medical treatment costs by enabling our customers to sharehave control overand oversight of the medical treatment process.of their injured employees to ensure treatment is timely and appropriate. This control is primarily obtained by participation in one of our medical treatmentprovider networks. We hold several government-issued licenses to operate medical treatmentprovider networks. Through Medex, we hold two of athe total of sevenfour licenses issued by the state of California to establish and manage HCOs within the state of California. We also hold approvals issued by the state of California to act as an MPN and currently administer 2627 MPNs. Our HCO and MPN programs provide our customers with provider networks within which our customers havethe customer has some ability to direct the administration of employee claims.the claim. This is designed to decrease the incidence of fraudulent claims and disability awards and ensure injured employees receive the necessary back-to-work rehabilitation and training they need. Our medical bill and utilization review services provide oversight of medical billing and treatment requests, along withand our medical case management which keeps medical treatmentworkers’ compensation claims progressing to a resolution and assures treatment plans are aligned from a medical perspective.

 

Our customers include self-administered employers, insurers, third party administrators, municipalities, and others. Our principal customers are companies with operations located in the state of California where the cost of Workers’ Compensationworkers’ compensation insurance is a critical problem for employers, though we are able to process medical bills nationally.bill reviews, utilization reviews and provide medical case management in several other states. Our provider networks, which are located only in California, are composed of providers experienced in treating worker injuries.

 

Our business generally has a long sales cycle, typically eight months or more. Once we have established a customer relationship and enrolled employees of our employer customers, we anticipate our revenue to adjust with the growth or retraction of our customers’ employee headcount. Throughout the year, we also expect to add new employees and employer customers to be added while others terminate for a variety of reasons. The reasons for termination vary but include when a customer switches to an insurance carrier or third party administrator that uses a different workers’ compensation administration vendor, or when our contract ends with state and local governments.

 

11

Impact of COVID-19 on our Business

 

In February 2022, California passed anotherthe COVID-19 Supplemental Paid Sick Leave law (“CSPSL”). It providesprovided employees paid leave for COVID-19 related reasons such as caring for themselves, family members, or for vaccine related appointments or illnesses caused by COVID-19 or the vaccine from January 1, 2022 through September 30, 2022. The CSPSL allowsallowed employees to retroactively request reimbursement for qualifying leave or to use it towards future requests through September 30, 2022. Employers whose employees utilizeutilized CSPSL are ineligible for federal tax credits to offset the costs of providing the CSPSL. On September 29, 2022, California passed a bill that extended the CSPSL leave through December 31, 2022, and provides a supplemental paid sick leave relief grant program for employers for reimbursement of CSPSL. As of the date of this report, the CSPSL relief grant program is still in development and unavailable to be reimbursedapply for. When it becomes available, we intend to apply for the CSPSL.reimbursement of CSPSL leave.

 

We willWhile the CSPSL leave expired on December 31, 2022, we continue to offer COVID-19-specific paid leave benefits to our employees until the expiration of CSPSL. Family,have family, medical, and other types of leave remain available to employees under existingpre-existing Company policy. As of September 30, 2022,the date of this report, California has not passed additional COVID-19 related sick leave laws.

Unlike much of the U.S. economy, we have incurred negligible payroll, benefits, administrative,maintained relatively steady employee recruitment and liabilityretention. Our maintenance of a successful remote environment, including high employee morale and cohesive culture via technology, has also allowed us to seek candidates in a wider range of locations, some of which have lower costs relatedof living and lower wage norms, as well as increasing the quantity of qualified applicants. While we cannot predict or control future trends in labor in our industry, we believe that our solid recruitment practices and the opportunities presented by remote work options will help us adapt to CSPSL. However,a changing workforce environment.

We have opted to keep the majority of our workforce remote and we have taken measures to ensure data security, but there is no guarantee that these measures will be completely effective, that our productivity will not be adversely impacted, or that we will not encounter other risks associated with a remote workforce, such as increased loss of direct control of and reliance on third party information systems required for us to run our business. As discussed in greater detail in Item 1A Risk Factors of our Annual Report, our business has been and could incur some significant costs if additional booster shots are recommendedcontinue to be materially and adversely affected by the interruptions and changes to our business operations resulting from or required later in 2022, or if another spike in COVID-19 results in increased usageresponse to COVID-19.

13

 

Key trends affecting results of operations

 

As noted throughout this quarterly report, duringDuring the three and nine months ended September 30,March 31, 2023 and 2022, and 2021, COVID-19 has impactedcontinued to impact the businesses of our customers our business and our results of operations. Most of our customers, and their employees are located in California. During the three and nine months ended September 30, 2021, California had in place COVID-19 restrictions on businesses which resulted in many ofMarch 31, 2022, our customers reducing their workforces and caused a decrease in the number of new workers’ compensation claims, as a result of fewer workers in the labor force. Allowable medical treatment for workers’ compensation claims were also limited to help ease the burden of COVID-19 on medical facilities. During the three and nine months ended September 30, 2022, California businesses were able to operate without these COVID-19 restrictions and restrictions on allowable medical treatments for workers’ compensation claims were lifted. As identified in more detail in our discussion of result of operations below, during the three and nine months ended September 30, 2022, the lifting of these restrictions has generally led to increased demand from existing customers for our services, as their employees returned to the workforce and correlated workplace injuries increased, along with medical facilities and providers having the capacity to begin treating the backlog of workplace injuries that occurred when allowable treatment restrictions due to COVID-19 were in place. We anticipate the foregoing trends will continue at decreasing rates over future periods as the remaining workforces that return to in-person work levels off and the backlog of untreated workers’ compensation cases normalizes. These trends have also contributed to increased claims-related expenses for services provided to us by third parties, as certain such expenses increase in correlation with the demand for our services.

California has in place legislation to address employer liability in Workers’ Compensation for COVID-19 cases. The law presumes that COVID-19 illnesses contracted by employees are work related and therefore eligible for workers’ compensation coverage, subject to certain rebuttable presumptions. Our customers experiencedhad an increase in COVID-19 related workers’ compensation claims throughout 2021as the economy opened back up and duringpeople returned to their offices, but as immunity and use of vaccines increased, COVID-19 related workers’ compensation claims has decreased through the first quarter of 2023. The decline in COVID-19 related workers’ compensation claims since the end of the first quarter of 2022 butthrough the first quarter of 2023 has adversely affected the revenues generated from claim network fees when a claim is opened, as well as fees generated when a medical case manager is assigned to the claim.

During the first quarter of 2023, we saw a slight increase in the number of employees enrolled in our HCO and MPN programs; however, given the current economic outlook we could see declines in COVID-19 related claimsenrollees for future periods. The enrollment numbers in our HCO and MPN programs generally correlate with general economic conditions and the size and activities of our customers’ workforce. If economic conditions continue to be challenging, including from the effects of inflationary pressures, elevated interest rates, and challenging labor market conditions, our customers may reduce their workforce, in which case we would expect a decline in the secondnumber of employees enrolled in our HCO and third quartersMPN programs in future periods and in related revenues.

During the fourth quarter of 2022. For2022 and through the nine months ended September 30, 2022, approximately 8%first quarter of all claims2023, we processed have been COVID-19 related, with 53% of those claims occurringexperienced difficulties when transitioning between new software vendors for our utilization review and medical case management services. Throughout these software transitions, our automated processes had to be performed manually, which caused delays in providing services and invoicing our customers, reduced productivity and resulted in additional outsourcing costs. Our revenues continued to be adversely impacted in the first quarter of 2022. During2023 as a result of the twelve months ended December 31, 2021, approximately 5%interruptions and costs associated with these software transition difficulties. While the new software is now nearly functional, certain functionalities are still being developed. As of all claims processed were COVID-19 related.the date of this report, we believe the delayed invoicing problems have been addressed and we expect that the outstanding accounts receivable will decrease, and utilization review and medical case management productivity will increase.

 

Revenue generated from COVID-19 workers’ compensation claimsAs previously disclosed in our Annual Report, Fortra, LLC, the third-party vendor that provides the GoAnywhere managed file transfer as a service system (MFTaaS), experienced a data security incident that affected many of Fortra’s customers, including the Company. As of the date of this report, this incident has not caused a material interruption of our business operations. Our investigation into the details of this incident is ongoing, but to the extent we discover further details of the data accessed, we will provide the appropriate notifications to any individuals affected by the incident, as well as to government and regulatory agencies as required by federal and state law. We have incurred expenses, and may become seasonal and as the frequency of contracting COVID-19 increases and the severity of cases decreases, it is possible thatincur in the future COVID-19 will no longerexpenses and losses, related to this incident, some of which may not be classified as a workers’ compensation illness in California. A portioncovered by cyber liability insurance. Further, because of the ongoing nature of our revenue is generated from fees frominvestigation into this incident and current unknowns, an estimate of the impacts on our customers when a workers’ compensation claim is opened. If the changebusiness, results of classification for COVID-19 related claims no longer requires employers to report it as a workers’ compensation injury, there wouldoperations and other potential liabilities cannot be a decrease in our COVID-19 related revenues, but we would anticipate this decrease would be offset by an increase in other workers’ compensation injuries as more employees return to the labor pool.made.

Some of our customers’ industries have been impacted by the recent national trend of workforce resignations and difficulties in hiring. If our customers cannot attract new workers, it is possible that some jobs will be replaced with technology. If technology replaces workers, and/or workplace injuries continue at lower rates because there are more employees working from home and fewer employees suffering injuries in the workplace, the increases in revenues we are beginning to see could flatten or decline.

Our revenues for medical case management were also impacted because there was a smaller labor pool which resulted in fewer new workers’ compensation claims. We believe this trend will be temporary, as the economy recovers from the effects of COVID-19, but if the trend to smaller labor pools continues, or if an economic recovery is slowed as a result of higher inflation or economic recession, medical case management reviews and resulting revenues could continue to remain lower in the future.

12

 

Revenue

 

We derive revenue primarily from fees charged for access to our HCO and MPN provider networks, enrollment of customers’ employees into the HCO or claim network fees, HCO/MPN program, utilization reviews,network administration, medical bill reviews, andreview, utilization review, medical case management services.services, Medicare set-asides, and network access.

 

HCO

 

HCO revenue is generated largely from fees charged to our employer customers for claim network fees to access our HCO networks, employee enrollment into our HCO program, program administration, custom network fees, annual and new hire notifications, and fees for other ancillary services they may select. HCO notifications are mailed out annually and handed out by the employer for all new hires.

 

MPN

 

Like HCO revenue, MPN revenue is generated largely from fees charged to our employer customers for claim network fees to access our MPN networks, custom network fees, employee enrollment into our MPNand program program administration, and fees for other services our MPN customers may select.administration. Unlike the HCO,HCOs, MPNs do not require annual and new hire notifications, MPNs are only required to provide a notice to an injured workeremployee at the time the employer is notified by the injured workeremployee that an injury occurred.

 

Utilization review

14


Utilization review is the review

 

Medical bill review

 

California and many other states have established fee schedules for the maximum allowable fees payable under workers’ compensation for a variety of procedures performed by medical providers. Many procedures, however, are not covered under the fee schedules, such as hospital bills, which still require review and negotiation. Medical bill review involves analyzing medical provider services and equipment billing to ascertain proper reimbursement. Such services include, but are not limited to, coding review and re-bundling, confirming that the services are customary and reasonable, fee schedule compliance, out-of-network bill review, pharmacy review, and preferred provider organization repricing arrangements. Our medical bill review services can result in significant savings for our customers. Revenue for medical bill reviews is generated based on a set fee per medical bill reviewed. Hospital bills generate revenue on a percentage of savings off the original amount, usually with a cap on the max amount we can charge for a hospital bill.

Utilization review

Utilization review is the review of medical treatment requests by providers to provide a safeguard for employers and injured employees against unnecessary and inappropriate medical treatment from the perspective of medical necessity, quality of care, appropriateness of decision-making, and timeliness of treatment. Its purpose is to reduce employer liability for medical costs that are not medically appropriate or approved by the relevant medical and legal authorities and the payor. We generate revenue when we receive a request for authorization of treatment from a claims adjuster. We bill by the number of treatment requests or by referral and the level of reviewer required to approve, modify, or deny the request.

 

Medical case management

 

Medical case management keepsoversees the injured employees’ medical treatment claims progressingto ensure that it progresses to a resolution and assures treatment plans are aligned from a medical perspective. Medical oversight is a collaborative process that assesses, evaluates, coordinates, implements and monitors medical treatment plans and the options and services required to meet an injured worker’s health needs. AOur medical case manager acts as a liaison betweenmanagement services are performed by nurses who are credentialed by the injured worker, claims adjuster, medical providers,state and attorneys to achieve optimal results for injured workershave expertise in various clinical areas and our employer customers.backgrounds in workers’ compensation matters. We work to manage the number of nurses in our program to maintain our ratio of claims per nurse at a level that ensures timely and appropriate medical care is given to the injured worker and facilitates faster claims closures for our customers. We generate revenue from these services when we receive a workers’ compensation claim and a medical case manager is assigned to oversee the injured workers’ medical treatment, with billing based on the number of hours a medical case manager works on the claim.

 

Other

 

Other revenue consists of revenue derived from network access fees charged to non-HCO, non-MPN customers to access our network of medical providers,for network access for preferred provider organizations, lien representation, legal support services, Medicare set-aside and Workers’ Compensation carve-out services.

 

13

The following table sets forth, for the threequarters ended March 31, 2023 and nine months ended September 30, 2022, and 2021, the percentage each revenue item identified in our unaudited condensed consolidated financial statements contributed to total revenue during the respective period.

 

 

For the three months ended

  

For the nine months ended

 
 

September 30,

  

September 30

 
 

2022

  

2021

  

2022

  

2021

  

2023

  

2022

 

HCO

  24%  22%  23%  24%  21

%

  25

%

MPN

  9%  11%  10%  10%  10

%

  10

%

Medical bill review

  7

%

  9

%

Utilization review

  31%  20%  29%  20%  34

%

  25

%

Medical bill review

  7%  9%  8%  7%

Medical case management

  26%  33%  28%  35%  25

%

  29

%

Other

  3%  5%  2%  4%  3

%

  2

%

15

 

Expense

 

Consulting fees

 

Consulting fees include fees we pay to third parties for IT, marketing, and in-house legal advice for the various services we offer.

 

Salaries and wages

 

Salaries and wages reflect employment-related compensation we pay to our employees, payroll processing, payroll taxes and commissions.

 

Professional fees

 

Professional fees include fees we pay to third parties to provide medical consulting, field medical case management, and board of director’s fees for board meetings, as well as legal and accounting fees.

 

Insurance

 

Insurance expense isexpenses are comprised primarily of health insurance benefits offered to our employees, directors’ and officers’ liability insurance, cyber security, Workers’ Compensation coverage and business liability coverage.

 

Outsource service fees

 

Outsource service fees consist of costs incurred by our subsidiaries in partially outsourcing utilization review, medical bill review, administrative services for medical case management and Medicare set-aside services and typically tend to increase and decrease in correlation with customer demand for those services.

 

Data maintenance fees

 

Data maintenance fees includesinclude fees we pay to a third party to process HCO and MPN employee enrollmentenrollments and HCO/host our HCO and MPN notifications. Theseprovider networks. HCO and MPN employee enrollment fees fluctuate throughout the year because of the varied timing of customer enrollment into our HCO or MPN programs, and the number of employees our customers have in their workforce.workforce, and the number of new hires throughout the year.

 

General and administrative

 

General and administrative expenses consist primarily of office rent, advertising, dues and subscriptions, equipment/repairs, IT enhancement, licenses and permits, telephone, office supplies, parking, postage, printing and reproduction, rent expense for equipment, miscellaneous expenses, shareholders’ expense, charity – cash contribution, auto expenses, bank charges, education, travel and entertainment, and vacation expense.

 

14

The following table sets forth, for the threequarters ended March 31, 2023 and nine-months ended September 30, 2022, and 2021, the percentage each expense item identified in our unaudited consolidated financial statements contributed to total expense during the respective period.

 

 

For the three months ended

  

For the nine months ended

 
 

September 30,

  

September 30

 
 

2022

  

2021

  

2022

  

2021

  

2023

  

2022

 

Depreciation

  1%  1%  1%  1%  1

%

  -

%

Bad debt provision

  -%  -%  -%  -%  -

%

  1

%

Consulting fees

  5%  5%  4%  5%  4

%

  5

%

Salaries and wages

  59%  57%  56%  57%  54

%

  54

%

Professional fees

  6%  6%  6%  6%  6

%

  6

%

Insurance

  7%  7%  7%  7%  7

%

  7

%

Outsource service fees

  13%  9%  12%  8%  14

%

  12

%

Data maintenance fees

  -%  1%  2%  2%  3

%

  1

%

General and administrative

  9%  14%  12%  14%  11

%

  14

%

16

 

Results of Operations

 

Comparison of the three months ended September 30,March 31, 2023 and 2022 and 2021

 

The following represents selected components of our consolidated results of operations for the three-month periods ended September 30,March 31, 2023 and 2022, and 2021, respectively, together with changes from period-to-period:period-to-period.

 

  

For three months ended

         
  

September 30,

         
  

2022

  

2021

  

Amount Change

  

% Change

 

Revenues:

                

HCO

 $354,913  $289,117  $65,796   23

%

MPN

  128,297   137,834   (9,537

)

  (7

%)

Utilization review

  443,049   258,251   184,798   72

%

Medical bill review

  99,418   117,685   (18,267

)

  (16

%)

Medical case management

  384,657   439,073   (54,416

)

  (12

%)

Other

  43,663   68,658   (24,995

)

  (36

%)

Total revenues

  1,453,997   1,310,618   143,379   11

%

                 

Expense:

                

Depreciation

  9,661   12,657   (2,996

)

  (24

%)

Bad debt provision

  (5,520

)

  -   (5,520

)

  -

%

Consulting fees

  56,148   58,275   (2,127

)

  (4

%)

Salaries and wages

  699,026   679,530   19,496   3

%

Professional fees

  76,065   76,014   51   -

%

Insurance

  79,974   86,527   (6,553

)

  (8

%)

Outsource service fees

  156,677   109,926   46,751   43

%

Data maintenance

  2,898   11,917   (9,019

)

  (76

%)

General and administrative

  112,135   168,939   (56,804

)

  (34

%)

Total expenses

  1,187,064   1,203,785   (16,721

)

  (1

%)

                 

Income from operations

  266,933   106,833   160,100   150

%

                 

Income before taxes

  266,933   106,833   160,100   150

%

Income tax provision

  74,928   29,987   44,941   150

%

                 

Net income

 $192,005  $76,846  $115,159   150

%

15

  

For three months ended March 31,

         
  

2023

  

2022

  

Amount Change

  

% Change

 

Revenues:

                

HCO

 $278,322  $360,968  $(82,646)  (23

%)

MPN

  129,094   148,611   (19,517)  (13

%)

Medical bill review

  89,785   120,337   (30,552)  (25

%)

Utilization review

  445,712   354,956   90,756   26

%

Medical case management

  332,373   418,762   (86,389)  (21

%)

Other

  37,357   23,749   13,608   57

%

Total revenues

  1,312,643   1,427,383   (114,740)  (8

%)

                 

Expense:

                

Depreciation

  9,379   4,195   5,184   124

%

Bad debt provision

  230   4,783   (4,553)  (95

%)

Consulting fees

  56,254   53,955   2,299   4

%

Salaries and wages

  662,224   633,372   28,852   5

%

Professional fees

  73,102   66,864   6,238   9

%

Insurance

  83,481   83,666   (185)  -

%

Outsource service fees

  177,759   143,778   33,981   24

%

Data maintenance

  34,002   10,189   23,813   234

%

General and administrative

  133,756   164,472   (30,716)  (19

%)

Total expenses

  1,230,187   1,165,274   64,913   6

%

                 

Income from operations

  82,456   262,109   (179,653)  (69

%)

                 

Other income (expense)

                

Interest income

  99,816   -   99,816   100

%

Total other income (expense)

  99,816   -   99,816   100

%

                 

Income before taxes

  182,272   262,109   (79,837

)

  (30

%)

Income tax provision

  (51,163

)

  (73,574

)

  22,411   (30

%)

                 

Net income

 $131,109  $188,535  $(57,426

)

  (30

%)

 

Revenue

 

HCO

 

During the three-month period ended September 30, 2022,March 31, 2023, HCO revenue increaseddecreased 23%, compared to the same period in the prior year. The increase was attributable to a renegotiation of certain deliverables to an existing customer and an increase in claims activity from existing customers which generated fees for notifications and claim network fees. These increases were partially offset by the loss of two customers in the fourth quarter of 2021, which decreased revenues from HCO enrollment. Part of the revenue generated in HCO fees is for the opening of workers’ compensation claims. During the three-month period ended September 30, 2022, 4% of HCO claims were COVID-19 related, compared to 5% in the same period in the prior year. If California legislation declassifies COVID-19 as a workers’ compensation claim, we expect HCO revenues to decrease.

MPN

MPN revenue for the three-month period ended September 30, 2022, decreased by 7%, compared to the same period in the prior year. The decrease in MPNHCO revenue was dueattributable to a decrease in the number claims reported due to the loss of a customer in the fourth quarter of 2021 that resulted in lower claims activity. Part of the revenue generated in MPN fees is for the opening ofCOVID-19 related workers’ compensation claims. The decrease in MPN revenue was partially offset by increases in claims activity by existing customers due to higher COVID-19 related claims. During the three-month period ended September 30, 2022, 30% of MPN claims were COVID-19 related, compared to 28% in the same period in the prior year. If California legislation declassifies COVID-19 as a workers’ compensation claim, we expect MPN revenues to decrease.

Utilization review

During the three-month period ended September 30, 2022, utilization review revenue increased 72%, compared to the same period in the prior year due to an increase in utilization reviews from existing customers and the addition of a new customer in the fourthfirst quarter of 2021. These increases were partially offset by decreases due to the loss of2022, there was a customer in the third quarter of 2021.

Medical bill review

During the three-month period ended September 30, 2022, medical bill review revenue decreased by 16%, compared to the same period in the prior year. The decrease was mainly due to processing fewer hospital bills from existing customers and the percentage of saving we earned on hospital bills processed was lower. Medical bill reviews are billed at a flat rate, while hospital bills are billed at a percentage of savings and fluctuate during the year.

Medical case management

During the three-month period ended September 30, 2022, medical case management revenue decreased 12%, compared to the same period in the prior year. The decrease in medical case management revenue was primarily due to customers electing not to apply medical case management to all of their COVID related claims in the 2022 period as they had done in the 2021 period and a decreasespike in the number of new referredreported COVID-19 related claims, managed with existing customers as a resultwhich accounted for 30% of fewer workplace injuries during 2020 and 2021 due to COVID related workforce restrictions.

Other

Otherthat quarter’s revenue for claim network fees. Since then, COVID-19 related claims have been moderately reported, as the three-month periodseverity and frequency of illness has declined, and California Sick Paid Leave “CSPSL” ended September 30, 2022, decreased 36%, comparedpaid time off for COVID-19 related illness, which we believe contributes to the same period in the prior year. The decrease in other revenue was the resultlower reporting of fewer Medicare set-aside claims and the discontinuation of our network referral access for non-HCO, non-MPN customers after the loss of our last customer who utilized the service in the fourth quarter of 2021.COVID-19 related illnesses. We do not anticipate futureexpect revenues from network referral fees generated from referrals to non-HCO, non-MPN customers, as we no longer offer this service. The decrease was partially offset by increases in fees for network access for preferred provider organizations, we expect other revenue to be lowermaterially affected by any further decline in future periods.

Expenses

Total expenses forCOVID-19 related claims, as the three month period ended September 30, 2022, decreased 1%, compared to the same period in the prior year. The decrease was attributable to decreases in depreciation, bad debt provision, consulting fees, insurance, data maintenance, and general and administrative partially offset by increases in salaries and wages and outsource service fees.number of remaining COVID-19 related claims is minimal.

 

16

Insurance

During the three-month period ended September 30, 2022, insurance expenses decreased 8%, compared to the same period in the prior year. The decrease in insurance expenses was primarily attributed to decreases in medical insurance premiums as a result of us having fewer employees in 2022, compared to 2021.

Outsource service fees

During the three-month period ended September 30, 2022, fees for outsourced services increased 43%, compared to the same period in the prior year. The increase was due to an increased demand for our services primarily from existing clients for utilization review, a service which we partially outsource.

General and administrative

During the three-month period ended September 30, 2022, general and administrative expenses decreased 34%, compared to the same period in the prior year. The decrease was primarily attributable to decreases in rent – office, auto expense, bank charges, charity – cash contributions, licenses and permits, travel, office supplies, postage, telephone, and vacation expenses. The largest decrease was in rent – office as we moved into a smaller office. The other various expenses that are part of maintaining a larger office such as postage, telephone, and office supplies were also lower as we adjusted our operations to take advantage of cloud based solutions. The decreases were partially offset by increases in advertising, dues and subscriptions, education, IT enhancement, meals, miscellaneous expenses, and parking. Due to moving most of our office operations to cloud or software services, dues and subscriptions for these services increased along with increases in IT security education for our employees and additional IT enhancements.

Income from operations

As a result of the $143,379 increase in total revenue during the three-month period ended September 30, 2022, and the $16,721 decrease in total expenses during the same period, our income from operations increased $160,100, or 150%, during the three-month period ended September 30, 2022, when compared to the same period in the prior year.

Income tax provision

We realized an increase in our income tax provision of $44,941, or 150%, during the three-month period ended September 30, 2022, compared to the same period in the prior year, because of the increase in income before taxes realized.

Net income

During the three-month period ended September 30, 2022, we realized an 11% increase in total revenues, a 1% decrease in total expenses, and a 150% increase in our provision for income tax when compared to the same period in the prior year. As a result, we realized a net increase of $115,159, or 150%, in net income during the three-month period ended September 30, 2022, compared to the same period in the prior year.

17

Comparison of nine months ended September 30, 2022 and 2021

The following represents selected components of our consolidated results of operations, for the nine-month periods ended September 30, 2022 and 2021, respectively, together with changes from period-to-period:

  

For nine months ended

September 30,

         
  

2022

  

2021

  

Amount Change

  

% Change

 

Revenues:

                

HCO

 $985,192  $936,382  $48,810   5

%

MPN

  422,227   396,497   25,730   6

%

Utilization review

  1,220,941   796,927   424,014   53

%

Medical bill review

  333,310   292,445   40,865   14

%

Medical case management

  1,218,077   1,381,929   (163,852

)

  (12

%)

Other

  102,084   174,251   (72,167

)

  (41

%)

Total revenues

  4,281,831   3,978,431   303,400   8

%

                 

Expense:

                

Depreciation

  23,153   35,964   (12,811

)

  (36

%)

Bad debt provision

  (737

)

  494   (1,231

)

  (249

%)

Consulting fees

  166,309   173,796   (7,487

)

  (4

%)

Salaries and wages

  2,018,638   2,073,133   (54,495

)

  (3

%)

Professional fees

  222,703   221,970   733   -

%

Insurance

  238,851   242,334   (3,483

)

  (2

%)

Outsource service fees

  433,275   304,085   129,190   42

%

Data maintenance

  59,400   75,293   (15,893

)

  (21

%)

General and administrative

  418,079   492,264   (74,185

)

  (15

%)

Total expenses

  3,579,671   3,619,333   (39,662

)

  (1

%)

                 

Income from operations

  702,160   359,098   343,062   96

%

                 

Other income (expense)

                

Paycheck protection program loan forgiveness income

  -   464,386   (464,386

)

  (100

%)

Paycheck protection program loan interest expense

  -   (3,686

)

  3,686   (100

%)

Total other income (expense)

  -   460,700   (460,700

)

  (100

%)

                 

Income before taxes

  702,160   819,798   (117,638

)

  (14

%)

Income tax provision

  197,096   140,956   56,140   40

%

                 

Net income

 $505,064  $678,842  $(173,778

)

  (26

%)

Revenue

HCO

During the nine-month period ended September 30, 2022, HCO revenue increased 5%, compared to the same period the prior year. The increase in HCO revenue was primarily attributable to an increase in claims from existing customers and renegotiation of certain deliverables to an existing customer. If California legislation declassifies COVID-19 as a workers’ compensation claim, we expect HCO revenues to decrease.

18

 

MPN

 

MPN revenue for the nine-monththree-month period ended September 30,March 31, 2023, decreased by 13%, compared to the same period in the prior year. The decrease in revenue was attributable to a decrease in the number of COVID-19 related workers’ compensation claims from which we generated claim network fee revenue in the first quarter of 2023. In the first quarter of 2022, COVID-19 related claims accounted for 35% of the quarter’s revenues for claim network fees. Since then, COVID-19 related claims have been moderately reported, mainly due to the reasons discussed in HCO revenue above, and we do not expect revenues to be materially affected by any further decline in COVID-19 related claims, as the number of remaining COVID-19 related claims is minimal. The decrease in MPN revenue was partially offset by increases in the number of enrollees into our monthly MPN program.

Medical bill review

During the three-month period ended March 31, 2023, medical bill review revenue decreased by 25%, compared to the same period in the prior year. The decrease was due to a decrease in hospital and non-hospital bills reviewed with existing customers, partially offset by the addition of a new customer in the fourth quarter of 2022.

Utilization review

During the three-month period ended March 31, 2023, utilization review revenue increased 26%, compared to the same period in the prior year. The increase in utilization review revenue was due to the addition of a new customer in the fourth quarter of 2022 and increases in utilization reviews from existing customers. We expect that the growth in utilization review will continue as our new operational software becomes fully functional but will level off once it is fully operational.

Medical case management

During the three-month period ended March 31, 2023, medical case management revenue decreased 21%, compared to the same period in the prior year. The decrease was attributable to a decline in COVID-19 related claims in the first quarter of 2023, fewer medical case management claims from existing customers, and disruptions stemming from difficulties and inefficiencies in transitioning to new operational software. In the first quarter of 2022, as COVID-19 related claims increased, the demand for medical case managers assigned to the claims increased. However, since the end of the first quarter of 2022, there has been a decline in the number of COVID-19 related claims and the correlated decline in assignment of claims to medical case managers, which has adversely impacted our medical case management revenues. Unless a new COVID-19 strain causes another severe outbreak, we expect that revenues from COVID-19 related claims to remain low as fewer COVID-19 related claims are reported and the severity of the illness does not require a medical case manager.

Other

Other revenue for the three-month period ended March 31, 2023, increased 57%, compared to the same period in the prior year. The increase was attributable to increases in the number of referrals for Medicare set-aside and network access fees.

Expenses

Total expenses for the three month period ended March 31, 2023, increased 6%, compared to the same period in the prior year. The increase was attributable to an increase in the number of claims reported by existing customers in the first quarter due to an increase in COVID-19 related claims,depreciation, consulting fees, salaries and wages, professional fees, outsource service fees, and data maintenance fees, partially offset by the loss of a customerdecreases in the fourth quarter of 2021. Like HCO revenue, MPN revenue is generated largely from fees charged to our employer customers for access to our MPN networks, per claim feesbad debt provision, and fees for other ancillary services. If California legislation declassifies COVID-19 as a workers’ compensation claim, we expect MPN revenues to decrease.general and administrative fees.

 

Utilization reviewDepreciation

 

During the nine-month periodthree months ended September 30, 2022, utilization review revenueMarch 31, 2023, depreciation expense increased 53%,by $5,184, compared to the same period in the prior year. The increase was primarily attributablethree months ended March 31, 2022, due to an increase in utilization reviews submitted by existing customers and a new customer added in the fourth quarterour disposing of 2021.fully depreciated fixed assets when we changed operational software systems.

 

Medical bill reviewProfessional fees

 

During the nine-month periodthree months ended September 30, 2022, medical bill review revenueMarch 31, 2023, professional fees increased by 14%, when9% compared to the same period in the prior year. This increase was primarily due to anthree months ended March 31, 2022. The increase in hospital and non-hospital bills reviewed as injured workers began seeking medical treatment for injuries suffered during the pandemic when medical treatment for workers’ compensation claims were subject to restrictions.

Medical case management

During the nine-month period ended September 30, 2022, medical case management revenue decreased by 12%, compared to the same period in the prior year. The decrease in medical case management revenue was primarily due to customers electing not to apply medical case management to all of their COVID related claims in the 2022 period as they had done in the 2021 period and a decrease in the number of new referred claims managed with existing customers as a result of fewer workplace injuries during 2020 and 2021 due to COVID related workforce restrictions.

Other

Other revenue for the nine-month period ended September 30, 2022, decreased 41%, compared to the same period in the prior year. The decreaseprofessional fees was primarily the result of fewer Medicare set-aside claims, fewer fees for network access for preferred provider organizations and the discontinuation ofincurred in providing our network referral access for non-HCO, non-MPN customers after the loss of our last customer who utilized thefield medical case management service, partially offset by decreases in the fourth quarter of 2021. As noted above, since the fourth quarter of 2021 we discontinued network referral access for non-HCO, non-MPN customers as this type of service is no longer offered in the marketplace, we expect other revenue to be lower in future periods.legal fees.

 

Expenses

18


Total expenses for the nine-month period ended September 30, 2022, decreased 1%, compared to the same period in the prior year. The decrease was the result

 

Outsource service fees

 

During the nine-month periodthree months ended September 30, 2022,March 31, 2023, outsource service fees increased 42%,24% compared to the same period the prior year. The increase was primarily the result of an increase in the volume of utilization reviews and medical bill reviews, partially offset by fewer Medicare set-aside claims.three months ended March 31, 2022. The increase in outsource service fees was attributable to outsourcing related to outsourcing certain functions that are normally performed by our operational software during the volume oftime we experienced problems in transitioning that software to a new vendor, a project in our HCO department, and increases in the demand for our services for our HCO program, Medicare set-asides, utilization review, and medical case management. The increase was partially offset by decreases in the outsourced services for medical bill review is due to injured workers now seekingfewer medical treatmentbills received.

We anticipate our outsource service fees will decrease once our operational software for injuries that occurred during the pandemic when treatments for workplace injuries were restricted,utilization review and medical case management is fully operational, as well as when our HCO department project is completed. Our outsourcing and related fees will continue to correspond with the level of medical bill review, utilization review, certain medical case management services and Medicare set-aside services we provide in the future.

Salaries and wages

During the three months ended March 31, 2023, salaries and wages increased 5% compared to the three months ended March 31, 2022. The increase in wages and salaries was related to such increases for our customers’ employees returningexisting employees. Given the current increased wage inflation trends, we expect salaries and wages will increase in future periods from our efforts to the workforceattract and getting injured on the job. The increased volume in these services required us to increase our usage of these outsourced services.retain employees.

 

Data maintenance

 

During the nine-month periodthree months ended September 30, 2022,March 31, 2023, data maintenance fees decreased 21%,increased by $23,813 from $10,189 to $34,002 compared the same period the prior year.three months ended March 31, 2022. The decreaseincrease in data maintenance fees was primarily the result of decreases in the number of claims from the loss of an MPN customer in the fourth quarter of 2021 that generates fees for MPN notifications, partially offset bydue to increases in our customers’ employee counts for enrollment into our HCO, and MPN programs.which resulted in increases in correlated data maintenance fees.

19

 

General and administrative

 

During the nine-month period ended September 30, 2022, generalGeneral and administrative expenses decreased by 15%,19% during the three months ended March 31, 2023, compared to the same period the prior year. Thisof 2022. The decrease was primarily attributabledue to decreases in auto expenses, bank charges,office rent, telephone, licenses and permits, and miscellaneous expenses relating to moving to a smaller office supplies, postage and delivery, printing and reproduction, rent expense - equipment, rent expense – office, shareholders’ expense, telephone, and vacation expense. Rent expense – office, telephone, and vacation expense, were 61%, 11%, and 16%, respectivelyat the end of the overall decreasesfirst quarter in expenses. Rent expense for office and telephone decreased in May 2022, when we moved office locations to a much smaller location and moved to a cloud based phone system.2022. The decreases weredecrease was partially offset by increases in advertising and marketing, auto expenses, banking fees, dues and subscriptions, education, equipment – equipment/repairs, IT enhancement/internet, meals, office supplies, meals/travel, miscellaneousparking, postage and delivery, and shareholders’ expenses.

While we anticipate certain general and administrative expenses will remain lower in the long-term, such as office rent, internet and parking. IT enhancement, dues and subscriptions and miscellaneous expenses increased due to the office move, makingphone, as a result of changes to our business operations in response to COVID-19, we expect other general and administrative expenses, such as IT systemsenhancements, hardware and transitioning office software and phones to subscription based services.other technology-related expenses will remain at higher than historic levels in future periods.

 

Income from operationsOperations

 

Total revenues increased by $303,400As a result of the 8% decrease in total revenue during the three-month period ended March 31, 2023, and the 6% increase in total expenses decreased by $39,662, which led to an increase induring the same period, our income from operations of $343,062.

Other income (expense)

In February 2021, the principal and interest on the PPP loans issued to PHCO, MMC and MMM in April and May 2020, was forgiven in full. As a result, we realized income from paycheck protection loan forgiveness of $464,386 and loan interest expense from paycheck protection loans of $3,686decreased $179,653, or 69%, during the nine months ended September 30, 2021, resulting in total other income during the period of $460,700. During the correspondingthree-month period ended September 30, 2022, we realized no other income (expense).

Income tax provision

We realized a 40% increase in our income tax provision during the nine-month period ended September 30, 2022,March 31, 2023, when compared to the same period in the prior year.

Other Income (Expense)

In the first quarter of 2023, we had interest income of $99,816 from our investment in U.S. Treasury bills which mature on June 8, 2023.

Income Tax Provision

We realized a decrease in our income tax provision of $22,411, or 30%, during the three-month period ended March 31, 2023, compared to the same period in the prior year, because of the decrease in income before taxes realized.

19

Net Income

During the nine-monththree-month period ended September 30, 2022,March 31, 2023, we realized $343,062 morean 8% decrease in total revenues, a 6% increase in total expenses, and a 30% decrease in our provision for income from operations than duringtax when compared to the same period in the prior year. During the nine-month period ended September 30, 2021, we realized net other income of income of $460,700 PPP loan forgiveness. The other income realized from the PPP loan forgiveness in the 2021 period was exempt from federal income taxation, but not state income taxation, which was the primary contributing factor to why our income tax provision was higher in the 2022 period than the 2021 period despite the fact that our income before taxes was actually higher in the 2021 period.

Net income

As noted in the preceding paragraph, during the nine-month period ended September 30, 2022, we realized a $343,062 increase in income from operations compared to the prior year period. However, during the nine-month period ended September 30, 2021, we realized $460,700 in other income as a result of PPP loan forgiveness. We realized no other income during the nine-month period ended September 30, 2022. As a result, we realized net income of $131,109, a $173,778, or 26%30% decrease in net income during the nine-monththree-month period ended September 30, 2022,March 31, 2023, compared to the same period in the prior year.

 

Liquidity and Capital Resources

 

Liquidity is a measurement of our ability to meet our potential cash requirements for general business purposes. We consistently monitor our liquidity and financial position and take actions management believes are in the best interest of ourthe Company and ourits shareholders to ensure the long-term financial viability of ourthe Company. Historically, we have realized positive cash flows from operating activities, which, coupled with positive reserves of cash on hand, have been used to fund our operating expenses and obligations. We have not historically used, nor do we currently possess, a credit facility or other institutional source of financing.

As a result of the pandemic subsiding, restrictions being removed and employees returning to work, coupled with our efforts to transition the Company to a remote working environment, and reductions in overhead expenses, during the nine-month period ended September 30, 2022, we saw an increase in revenues and a decrease in expenses. We have continued to realize net income and net cash from operations and have increased our net cash position. Management currently believes that absent (i) any unanticipated further COVID-19 impacts, (ii) economic recession or a longer-term downturn in the general economy, (iii) further impacts related to rising or sustained inflation or the sanctions, countermeasures and other actions in response to the Russia-Ukraine conflict, or (iv) the loss of several major customers within a condensed period, cash on hand and anticipated revenues from operations will be sufficient to cover our operating expenses for at least the next twelve months, as well as for the longer term.

20

As of September 30, 2022, we had cash on hand of $10,640,063 compared to $10,085,372 as of December 31, 2021. The $554,691 increase was the result of net cash provided by our operating activities, partially offset by cash used in investing activities.

We took advantage of both the First Draw and Second Draw Paycheck Protection Programs. Because the funds were used as designated under those programs, we received full forgiveness of all PPP loans received. In the future we may further avail ourselves of federal, state, or local government programs to protect our workforce as management and our board of directors determine to be in the best interest of the Company and our shareholders.

 

We have focused on reducing other operating expenses while maintaining our ability to provide the high-quality services to which our customers are accustomed. In December 2022, we renewed our office lease for an additional 12-month period which will expire March 31, 2024. As a result of relocating to a smaller office and continuing to have our employees work remotely, we have decreased the operating costs for office expenses, but have utilized some of those savings to enhance our IT security as well as other IT enhancements.

We currently have planned certain capital expenditures including changingto replace our operational software, the processlaptops due to their age and as part of which we are currently undergoing.our ongoing continuity plan. We anticipate the costinvesting activities will continue throughout 2023 as we replace aging software, computer equipment, and further enhance our IT security. We anticipate these costs to change operational software will result in significantly higher capital expenditures than in previous years. We encountered difficulties with the first software vendor in this transition and have had to seek another software vendor, the result of which has delayed this transition and increased capital expenditures for this project. If we encounter further issues or delays with the transition capital expenditures could be higher than anticipated,significant, but we believe we have adequate capital on hand to cover these expenses. We do not anticipate these expenditures will require us to seek outside sources of funding.

 

We believeDuring the first quarter of 2023, we realized net income of $131,109, as a result of unrealized interest income from our stronginvestment in Treasury bills and income from operations during that period. As of March 31, 2023, we had $1,994,841 cash position could allow uson hand compared to identify$2,036,432 at December 31, 2022. The $41,591 decrease in cash on hand was largely due to the effects from our difficulties with our operational software transition during the fourth quarter of 2022 and capitalize on potential opportunities to expand our business through the first quarter of 2023. Although the decrease in cash flow resulted in us using cash reserves to support operations during the first quarter of 2023, we do not expect cash flow issues moving forward. As such, management currently believes that absent (i) any unanticipated further adverse impacts related to COVID-19, (ii) an increased or longer-term downturn in the general economy, (iii) increases in or sustained inflation, (iv) the loss of several major customers within a condensed period of time or (v) additional software issues, cash on hand and anticipated revenues from operations will be sufficient to cover our operating expenses for at least the next twelve months.

We had a decrease in cash on hand in fiscal 2022 from our investment in U.S. Treasury bills that will mature on June 8, 2023. We intend to continue to pursue potential acquisition of existing businessestransactions that, may have insufficient resourcesif additional cash on hand were needed for such transaction, we would either need to overcome the impactscondition closing upon maturity of the COVID-19 pandemicbills or current uncertain economic conditions. Such expansion could occur through accretion to existing business linesseek alternate financing, or expansion into new business lines and related industries, including, but not limited to, the insurance industry.a combination of those approaches. We may also seek growth through organic development of new lines of business or expansion of existing offerings. Depending upon the nature of the opportunities we identify, such acquisitions or expansion could require greater capital resources than we currently possess. Should we need additional capital resources, we couldwould seek to obtain such through debt and/or equity financing. We do not currently possess an institutional source of financing and there is no assurance that we could be successful in obtaining equity or debt financing when needed on favorable terms, or at all. We could also use shares of our capital stock as consideration for a business acquisition transaction, but there is also no assurance that there would be significant interest in our capital stock by a potential seller or the market.

 

As a result of the unique nature of the COVID-19 pandemic and its impacts on our operations, the operations of our customers and the broader economy, coupled with uncertainty surrounding the potential impacts ofcontinued challenging economic conditions such as rising inflation, or economic recession,elevated interest rates and challenging labor market conditions, we cannot provide any assurance that the assumptions management has used to estimate our liquidity requirements will remain accurate in either the short-term or the longer-term. The ultimate duration and impact of these events on our business, results of operations, financial condition and cash flows is dependent on future developments, which are uncertain, largely beyond our control and cannot be predicted with any degree of certainty at this time. WeHowever, we expect that our results of operations, including revenues, in future periods will continue to be partiallyadversely impacted by the COVID-19 pandemic due toand continued challenging economic conditions, and their negative effects on our business and the possibility that as COVID-19 becomes more common and less severe that COVID-19 workers’ compensation claims may no longer be classified as a workers’ compensation illness. We expect that with rising inflation profit margins will be impacted due to fixed pricing for somebusinesses of our public entity customers and the increasing costs in salaries and wages as we compete to recruit and retain employees.customers.

Cash flow

During the nine months ended September 30, 2022, cash was primarily used to fund operations. We had a net increase in cash of $554,691 during the nine months ended September 30, 2022. See below for additional information.

  

For the nine months ended

September 30,

 
  

2022

(unaudited)

  

2021

(unaudited)

 
         

Net cash provided by operating activities

 $572,310  $449,993 

Net cash used in investing activities

  (17,619)  (12,199

)

Net cash provided by financing activities

  -   218,900 
         

Net increase in cash

 $554,691  $656,694 

 

21
20

 

Cash Flow

During the ninethree months ended September 30,March 31, 2023, cash was primarily used to fund operations. We had a net decrease in cash of $41,591 during the three months ended March 31, 2023. See below for additional discussion and analysis of cash flow.

  

For the three months ended March 31,

 
  

2023

(unaudited)

  

2022

(unaudited)

 
         

Net cash provided by (used in) operating activities

 $(41,382

)

 $459,370 

Net cash used in investing activities

  (209

)

  (6,133

)

Net cash provided by financing activities

  -   - 
         

Net (decrease) increase in cash

 $(41,591

)

 $453,237 

For the three months ended March 31, 2023, net cash used in operating activities was $41,382, whereas for the three months ended March 31, 2022, and 2021, net cash provided by operating activities was $572,310 and $449,993, respectively, an increase$459,370; a decrease of $122,317. This increase$494,828. The $494,828 decrease in cash flow from operations during the first quarter of 2023 was primarily the result of decreasesrealizing lower net income coupled with increases in accounts receivable, deferred rent asset, income tax receivable, other assets, accrued expenses, partially offset by increases in allowance for bad debt, prepaid expenses, accounts payable, income tax payable and unearned revenue. We realized higher net income duringrevenue, partially offset by decreases in prepaid expenses, accounts payable, and accrued expenses. A portion of the nine months ended September 30, 2021, thanincrease in accounts receivable was due to the same period 2022, asdelays in invoicing customers stemming from the problems in transitioning our operational software for utilization review and medical case management, a result of receiving PPP loan forgiveness in the amount of $460,700 during the 2021 period.problem we believe has been resolved.

 

Net cash used in investing activities was $17,619$209 and $12,199$6,133 during the nine-monththree month periods ended September 30,March 31, 2023 and 2022, and 2021, respectively. During the nine-month periods ended September 30, 2022 and 2021,The increase in net cash was used in investing activities toduring the first quarter of 2023 was a result of our purchase new software and other IT enhancements.of computer equipment.

 

During the ninethree months ended September 30,March 31, 2023 and 2022, we did not engage in any financing activities. Net cash provided by financing activities during the nine months ended September 30, 2022, was $218,900. In April 2021, MMM received a Second Draw PPP loan in the amount of $218,900, that was fully forgiven with accrued interest in December of 2021.

 

Off-balanceOff-Balance Sheet Financing Arrangements

 

As of September 30, 2022,March 31, 2023, we had no off-balance sheet financing arrangements.

 

Inflation

         

We experience pricing pressures in the form of competitive pricing. Insurance carriers and third-party administrators compete against us for customers by offering bundled claims administration services with their own managed care services at a lower rate. We are also impacted by rising costs for certain inflation-sensitive operating expenses such as labor and employee benefits and facility leases. We believe that these impacts can be material to our revenues or net income. Some of our customers are public entities which contract with us at a fixed price for the term of the contract. Increases in labor and employee benefits can reduce our profit margin over the term of these contracts. See also “Effectsthe effects of inflation”inflation may have a disproportionate impact on our business of Item 1A Risk Factor of our Annual Report on Form 10-K filed with the Commission on April 14, 2022.Report.

 

Critical Accounting Policies and Estimates

 

Our consolidated financial statements are prepared in accordance with GAAP.accounting principle generally accepted in the United States (“GAAP”). Application of these principles requires us to make estimates, assumptions, and judgments that affect the amounts reported in our consolidated financial statements and accompanying notes. Because of the inherent uncertainty in making estimates and judgments, actual results could differ from our estimates and judgments. Our critical accounting policies are disclosed in Note 2, Significant Accounting Policies, of the Notes to Consolidated Financial Statements in our Annual Report and Note 1 and Note 2 to the Notes to the Condensed Consolidated Financial Statements in this report.

We continually evaluate our accounting policies, estimates and judgments and base our estimates and judgments on historical experience and various other factors that we believe to be reasonable under the circumstances. Because of the inherent uncertainty in makingOur critical accounting estimates and judgments, actual results could differ from our estimates and judgments. We consider (i) revenue recognition, (ii)include leases, (iii) allowance for uncollectible accounts, and (iv) income taxes, to be the most criticaland are discussed in more detail below. Such accounting policies because they relate to accounting areas thatestimates require the most subjective or complex judgments by us, often as a result of the need to make assumptions regarding matters that are inherently uncertain, and as such,actual results could be most subject to revision as new information becomes available.differ materially from these estimates. 

21

 

Revenue recognitionLeases:: We recognize revenue when control of the promised services is transferred to our customers in an amount that reflects the consideration we expect to be entitled to in exchange for those services. As we complete our performance obligations which are identified below, we have an unconditional right to consideration as outlined in our contracts with our customers. Generally, our accounts receivables are expected to be collected in 30 days in accordance with the underlying payment terms.

We offer multiple services under our managed care and network solutions service lines, which the customer may choose to purchase. These services are billed individually as separate components to our customers. Revenue is recognized as the work is performed in accordance with our customer contracts. Based upon the nature of our products, bundled managed care elements are generally delivered in the same accounting period. Advance payments from subscribers and billings made in advance are recorded on the balance sheet as unearned revenue.

Leases: We determine if an arrangement includes a lease at inception. Right-of-use assets represent our right to use an underlying asset for the lease term; and lease liabilities represent our obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and short-term and long-term lease liabilities, as applicable.

22

 

Operating lease liabilities and their corresponding right-of-use assets are initially recorded based on the present value of lease payments over the expected remaining lease term. The interest rate implicit in lease contracts is typically not readily determinable. As a result, we utilize our incremental borrowing rate to discount lease payments, which reflects the fixed rate at which we could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment. Our leases may include options to extend or terminate the lease which are included in the lease term when it is reasonably certain that we will exercise any such options. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

 

Allowance for uncollectible accountsUncollectible Accounts:: We determine our allowance for uncollectible accounts by considering severala number of factors, including the length of time trade accounts receivablesreceivable are past due, our previous loss history, the customers’ current ability to pay their obligationsits obligation to us, and the condition of the general economy and the industry as a whole. We write off accounts receivablesreceivable when they become uncollectible.

 

We must make significant judgments and estimates in determining contractual and bad debt allowances in any accounting period. One significant uncertainty inherent in our analysis is whether our past experience will be indicative of future periods. Although we consider future projections when estimating contractual and bad debt allowances, we ultimately make our decisions based on the best information available to us at the time the decision is made. Adverse changes in general economic conditions or trends in reimbursement amounts for our services could affect our contractual and bad debt allowance estimates, collection of accounts receivables,receivable, cash flows, and results of operations. Two customersAt March 31, 2023, one customer accounted for 10% or more of accounts receivable compared to two customers at September 30, 2022 and 2021, respectively.March 31, 2022.

 

Accounting for income taxesIncome Taxes:: We record a tax provision for the anticipated tax consequences of our reported results of operations. The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance, if necessary, to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

 

We recognize tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.

 

Management believes it is more likely than not that forecasted income, including income that may be generated as a result of certain tax planning strategies, together with future reversals of existing taxable temporary differences, will be sufficient to fully recover the deferred tax assets. In the event we determine all, or part of the net deferred tax assets are not realizable in the future, we will make an adjustment to the valuation allowance that would be charged to earnings in the period such determination is made. In addition, the calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of GAAP and complex tax laws. Resolution of these uncertainties in a manner inconsistent with management’s expectations could have a material impact on our financial condition and operating results. The significant assumptions and estimates described above are important contributors to our ultimate effective tax rate in each year.

 

23
22

 

Item 3. Quantitative and Qualitative Disclosure about Market Risk

 

Smaller reporting companies are not required to provide this information.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, which are controls and other procedures that are designed to provide reasonable assurance that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

 

Our management, under the supervision and with the participation of our principal executive officer and principal financial officer, conducted an evaluation the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report on Form 10-Q. Based on the evaluation of our disclosure controls and procedures as of September 30, 2022,March 31, 2023, the end of the period covered by this report, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2022,March 31, 2023, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

 

2423

 

PART II. OTHER INFORMATION

Item 1A. Risk Factors

 

Except for the following risk factor, we doManagement does not believe there have been any material changes to the risk factors listed in Part I, Item 1A, Risk Factors in our annual report. The below risk factor and risk factors in our annual report could materially adversely affect our business, financial condition, or results of operations, and should be carefully considered with the information provided elsewhere in this report.

We are reliant on the timely, accurate and consistent provision of outsourced services for various services and business functions, the disruption, malfunction, termination or replacement of which could impede our ability to provide our services and adversely affect our business.

We contract with various third party vendors for the provision and support of our services and business functions, including the critical information systems functionality upon which our services rely. Our business is dependent upon our ability to provide, in an efficient and uninterrupted manner, necessary business functions which we outsource, such as the processing and support of enrollment in our HCO and MPN programs, and the partial outsourcing of our utilization review, medical bill review, administrative services for medical case management and Medicare set-aside services. Our operations may be adversely affected if there is a failure, disruption or malfunction in the provision of such outsourced services, or if the relationship with or services provided by our vendors are terminated in whole or in part. Further, we may not be able to find an alternative vendor in a timely manner, on acceptable terms or that can provide the services of our current vendors.

Outsourcing also may require us to change our existing operations or adopt new processes for providing or managing our services. If there are delays or difficulties in changing business processes or our third-party vendors do not perform as expected, it may delay our ability to provide our services and we may not realize, or not realize on a timely basis, the anticipated functionality or benefits of these relationships. Terminating or transitioning, in whole or in part, arrangements with vendors could result in additional costs or penalties, risks of operational delays and interruptions, or potential errors and control issues during the termination or transition phase. For example, we have had difficulties implementing a new operational software system and are seeking a different vendor to provide that system, which has resulted in delays in implementing this project and additional capital expenditures. If there is an interruption in our ability to provide our services or loss of access to data resulting from a malfunction, termination or transition in outsourced services, we may not be able to meet the demands of our customers and, in turn, our business and results of operations could be adversely impacted.Annual Report.

 

Item 6. Exhibits

 

Exhibits. The following exhibits are filed or furnished, as applicable, as part of this report:

 

Exhibit Number

 

Title of Document

 

 

 

Exhibit 31.1

 

Certification of Principal Executive Officer pursuant to Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

Exhibit 31.2

 

Certification of Principal Financial Officer pursuant to Rule 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

Exhibit 32.132

 

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

Exhibit 101

 

Pursuant to Rules 405 and 406 of Regulation S-T, the following information is formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Unaudited Condensed Consolidated Balance Sheets as September 30, 2022March 31, 2023 and December 31, 2021,2022, (ii) the Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30,March 31, 2023 and 2022, and 2021, (iii) the Unaudited Condensed Consolidated Statements of Stockholder’s Equity for the three and nine months ended September 30,March 31, 2023 and 2022 and 2021 (iv) the Unaudited Condensed Consolidated Statements of Cash Flows for the ninethree months ended September 30,March 31, 2023 and 2022, and 2021, (v) Notes to the Unaudited Condensed Consolidated Financial Statements, and (vi) the cover page.

   

Exhibit 104

 

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

2524

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

PACIFIC HEALTH CARE ORGANIZATION, INC.

 

 

 

 

Date:

November 14, 2022May 18, 2023

/s/ Tom Kubota

 

 

 

Tom Kubota

Chief Executive Officer

 

 

 

 

 

Date:

November 14, 2022May 18, 2023

/s/ Kristina Kubota

 

 

 

Kristina Kubota

Chief Financial Officer

 

 

2625
iso4217:USD xbrli:shares